Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry corresponds to a pseudogene homologous to ubiquitin-like modifier activating enzyme 2 (UBA2). Pseudogenes are DNA sequences similar to known genes but generally lack the ability to encode a functional protein. They may retain sequence homology to their ancestral gene and, in rare cases, may play regulatory roles as noncoding RNAs, but this function is not established for this specific pseudogene. UBA2 itself is a protein-coding gene involved in the sumoylation pathway essential for protein modification and cell regulation, but ENSG00000270983 does not participate directly in these biological functions[2][5][6]. Key points: - ENSG00000270983 is a nonfunctional genetic element and not a druggable therapeutic target. - No protein, drug interactions, or direct biomarker utility is documented. - It is not equivalent to UBA2 (which is a functional enzyme); the pseudogene only shares sequence similarity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin-like modifier activating enzyme 2 pseudogene.